6505NCM217197: MIDAZOLAM NASAL SPRAY.
The MIDAZOLAM NASAL SPRAY is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: MIDAZOLAM NASAL SPRAY, 2S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-696-1705, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | MIDAZOLAM NASAL SPRAY, 2S |
| NSN | 6505-01-696-1705 |
| SPECIAL FEATURES | INDICATED FOR THE ACUTE TREATMENT OF INTERMITTENT, STEREOTYPIC EPISODES OF FREQUENT SEIZURE ACTIVITY (I.E., SEIZURE CLUSTERS, ACUTE REPETITIVE SEIZURES) THAT ARE DISTINCT FROM A PATIENT'S USUAL SEIZURE PATTERN IN PATIENTS WITH EPILEPSY 12 YEARS OF AGE AND OLDER; SUPPLIED AS A SINGLE-DOSE NASAL SPRAY UNIT CONTAINING 5 MG OF MIDAZOLAM IN 0.1 ML SOLUTION; SUPPLIED IN BOXES OF 2 NASAL SPRAY UNITS, EACH CONTAINED WITHIN AN INDIVIDUAL BLISTER PACK; DO NOT OPEN THE BLISTER PACKAGING UNTIL READY TO USE; STORE AT CONTROLLED ROOM TEMPERATURE 20 C TO 25 C (68 F TO 77 F), EXCURSIONS PERMITTED TO 15 C TO 30 C (59 F TO 86 F); SHELF LIFE: 12 MONTHS. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | MIDAZOLAM NASAL SPRAY, 2S |